socalTECH

OCTOBER 25, 2017

La Jolla-based Avalon Ventures is the lead investor in the Series A round for Averon , a developer of mobile identity verification software this week. Avalon's Rich Levandov and Brady Borhmann both join Averon's board with the funding round. Averon, which is based in San Francisco, said it has raised $8.3M in a Series A funding.

Avalon 100

Avalon Commerce Mobile Software 100

socalTECH

MAY 20, 2016

San Diego-based Avalon Ventures , and COI Pharmaceuticals , the company established by Avalon to help form new biotech companies, said today that the first two companies that it has formed with GlaxoSmithKline have met their first milestones, and that it has spun up a new company with GSK as part of their collaboration. READ MORE>>.

Avalon 113

Avalon Company Companies San Diego 113

socalTECH

JULY 14, 2015

San Diego-based venture investor Avalon Ventures is the lead investor in a new, $10M funding round for AeroFS , a developer of private cloud collaboration software. Avalon's Rich Levandov represents Avalon Ventures on the AeroFS board. AeroFS said the Series B funding also included NHN Investment. READ MORE>>.

Avalon 100

Avalon San Diego Software Invest 100

socalTECH

JUNE 15, 2015

San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.

Avalon 100

Avalon San Diego Startup Funding 100

socalTECH

SEPTEMBER 11, 2019

San Diego-based biotech investor Avalon Ventures has scored an exit, saying late Tuesday evening that it has entered into a definitive agreement with GlaxoSmithKline (GSK), to sell Sitari Pharmaceuticals to GSK. Sitari was developing treatments for celiac disease, and was being incubated at COI Pharmaceuticals.

Avalon 100

Avalon San Diego Incubator Develop 100

socalTECH

MARCH 21, 2018

La Jolla-based venture investor Avalon Ventures is the lead investor in a round for San Francisco-based Averon , a developer of mobile identity verification software. The funding was led by Avalon Ventures, and also included Salesforce founder and CEO Marc Benioff. Avalon Ventures' investment was managed by Brady Bohrmann.

Avalon 100

Avalon Mobile Software Networking 100

socalTECH

NOVEMBER 22, 2013

San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals , with $10M in a Series A financing.

Avalon 153

Avalon San Diego Capital Funding 153

socalTECH

OCTOBER 22, 2014

San Diego-based StackIQ , which develops IT automation tools for the enterprise, has raised $6M in a Series B funding round, according to the company. The new funding came from Grayhawk Capital, Keshif Ventures, DLA Piper, and OurCrowd, as well as Anthem Venture Partners and Avalon Ventures. The company is led by Tim McIntire.

Avalon 174

Avalon Anthem San Diego Venture Capital 174

socalTECH

MARCH 5, 2013

San Diego-based Carolus Therapeutics , a developer of biopharmaceuticals aimed at treating acute and chronic inflammation, has scored $2.25M in a debt funding round, according to financing provider Square 1 Bank. According to Square 1, the new funding will go support future growth at Carolus. READ MORE>>.

Avalon 147

Avalon Funding San Diego Develop 147

socalTECH

DECEMBER 6, 2012

The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients. The firm's technology is based on technology developed by Nobel Prize winner Roger Tsien, Ph.D. The firm's CEO is currently Jay Lichter, who is also a Managing Director at Avalon Ventures.

Avalon 138

Avalon San Diego Study Technology 138

socalTECH

JULY 17, 2014

for San Diego''s Veredezyne , which is developing biofuels and biochemicals processes. Patrick Soon-Shiong, which raised $135M in a funding; El Segundo-based Prodege (aka Swagbucks), which raised $60.1M for its consumer loyalty and advertising efforts; nearly $49.0M for San Diego-based biopharmaceuticals firm Otonomy ; and $48.0M

Southern California 240

Southern California El Segundo Culver City Orange County 240

socalTECH

AUGUST 30, 2010

San Diego-based Otonomy , a biopharmaceuticals firm developing products to treat disorders of the inner and middle ear, announced today that it has raised $38.5M The round was led by Novo Ventures and RiverVest Venture Partners, and also includes Domain Associates, TPG Biotech, and Avalon Ventures. in a Series B financing.

Avalon 150

Avalon San Diego Venture Capital Study 150

socalTECH

JUNE 9, 2010

San Diego-based Otonomy , a biopharmaceuticals firm developing drug therapies to treat inner and middle ear disorders, has raised $10.56M as part of an ongoing, $26.0M fundraising effort, according to a regulatory filing by the firm.

Avalon 159

Avalon San Diego Venture Capital Capital 159

socalTECH

JANUARY 9, 2014

The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. Avelas Biosciences is developing a flourecent peptide which helps surgeons highlight cancer cells during surgery, specifically for breast cancer. READ MORE>>.

Avalon 138

Avalon San Diego Funding Capital 138

socalTECH

APRIL 20, 2012

San Diego-based Chumby , which had developed Internet-connected, alarm-clock like devices and similar technology, has shut down, according to a report Friday.

Report 157

Report Avalon San Diego News 157

socalTECH

JULY 21, 2011

San Diego-based Amira Pharmaceuticals , a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb , the firms said late Thursday. Amira Pharmaceuticals was venture backed by Avalon Ventures, Novo A/S,Prospect Venture Partners, and Versant Ventures.

Avalon 150

Avalon San Diego Venture Capital Capital 150

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. in a Series B funding.

Avalon 147

Avalon San Diego Venture Capital Research 147

socalTECH

DECEMBER 2, 2013

The developer of portable oxygen concentrators -- used as an alternative to bulky, oxygen canisters for those with chronic respiratory conditions like COPD -- said it plans to raised up to $86.25M in its public debut. Inogen is venture backed by Novo A/S, Versant Ventures, Arboretum Ventures, Avalon Ventures, AMV Partners, and others.

Avalon 153

Avalon Acquisition Marketing Develop 153

socalTECH

JUNE 9, 2009

San Diego-based aFraxis , a stealth-mode firm developing treatments for Fragile X Syndome and autism, has raised $750,000 in a funding round, according to a regulatory filing by the firm Tuesday. Details on the funding have not been announced, however, the company is venture backed by Avalon Ventures.

Avalon 100

Avalon San Diego Venture Capital Capital 100

socalTECH

JULY 14, 2014

San Diego-based Otonomy , the biopharmaceuticals firm which is developing treatment of diseases and disorders of the ear, has filed for an IPO, saying in a filing that it is looking to raised $86.25M in an offering on the NASDAQ Global Market. Otonomy said it intends to list under the symbol OTIC. Otonomy''s IPO is being underwritten by J.P.

Avalon 147

Avalon San Diego Acquisition Marketing 147

socalTECH

SEPTEMBER 23, 2010

San Diego-based Chumby , the developer of a Linux-based, programmable device which connects to Internet information, has linked with QNX Software Sytsems Co. , Chumby is headed by Derrick Oien, and backed by Avalon Ventures, JK&B Capital, Masthead Venture Partners, and O'Reilly AlphaTech Ventures. READ MORE>>.

Avalon 154

Avalon San Diego Research Platform 154

socalTECH

JUNE 1, 2010

Chumby develops a Wi-Fi enabled, Internet device which acts both as a clock as well as a connection into internet services like Weather, news, and more. According to the filing, the firm is in the midst of raising up to $9.786M in the round.

Avalon 150

Avalon San Diego Venture Capital News 150

socalTECH

SEPTEMBER 5, 2013

San Diego-based server side caching software developer Proximal Data has inked a deal with LSI Corporation , where LSI will integrate its server-side caching technology with a PCIe flash application acceleration product. Proximal Data is venture backed by Divergent Ventures and Avalon Ventures. READ MORE>>.

Avalon 138

Avalon San Diego Software Development Software 138

socalTECH

JULY 12, 2010

The firm said the contract covers developing antibodies that could be used by the military in antibody-based biosensors, including those that can detect bioterrorist threats. Anaptys is backed by Alloy Ventures, Avalon Ventures, Frazier Healthcare Ventures, Novo A/S, Numenor Ventures, and WS Investments.

Outsource Development 140

Outsource Development Avalon San Diego Research 140

socalTECH

JUNE 11, 2010

San Diego-based Otonomy , which is developing treatments for Meniere's disease, said today that it has raised $10M in a Series A financing round. The round came from Avalon Ventures. Otonomy is headed by Jay Lichter, who is also a managing director at Avalon Ventures. READ MORE>>.

Avalon 113

Avalon San Diego Study Capital 113

socalTECH

APRIL 30, 2014

San Diego-based biopharmaceuticals developer Otonomy --which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. The company said the new funding will go towards its product pipeline and a potential filing for regulatory approval of its lead compound.

Funding 138

Funding Avalon San Diego Capital 138

socalTECH

SEPTEMBER 1, 2009

San Diego-based Awarepoint , a developer of real-time location systems for the healthcare market, reported Monday that former Motorola CEO and Sun Microsystems President Ed Zander has joined its board. Awarepoint is developing RTLS systems based on the Zigbee wireless standard. Zander also sits on the boards of Netezza and NetSuite.

Avalon 133

Avalon San Diego Report Marketing 133

socalTECH

MARCH 31, 2020

San Diego-based AristaMD , a developer of telehealth software, which allows primary care providers to conduct and document electronic medical consultations, has raised $18M in a Series B funding round.

Funding 140

Funding Avalon San Diego Platform 140

socalTECH

MARCH 13, 2014

San Diego-based AnaptysBio , a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. According to AnaptysBio, it will receive an upfront license fee of $17M from TESARO, plus receive funding of costs incurred in related development programs, as part of an antibody program.

Avalon 138

Avalon San Diego Venture Capital Research 138

socalTECH

AUGUST 4, 2014

San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. The company is venture backed by Avalon Ventures, OrbiMed, Novo AS, TPG Biotech, Domain Associates, Rivervest Venture Partners, as well as others. and $16.00

Pricing 147

Pricing Avalon San Diego Acquisition 147

socalTECH

OCTOBER 4, 2010

Chumby has previously raised funding from Avalon Ventures, JK&B Capital, Masthead Venture Partners, and O'Reilly AlphaTech Ventures. Chumby's Internet device allows users to run information widgets, and includes tools for developers which makes it easy to create those software widgets to connect to Internet services.

Avalon 145

Avalon San Diego Venture Capital Software 145

socalTECH

AUGUST 13, 2014

The company is developing treatments for disorders of the inner ear. Otonomy was backed by Avalon Ventures, OrbiMed, Novo A/S, TPG Biotechnology Partners, Domain Associates, and Rivervest Venture Partners. The company raised $100M in the IPO. The company priced at the high end of its initial estimated IPO range, which was $14.00

Avalon 138

Avalon San Diego Pricing Acquisition 138

socalTECH

APRIL 17, 2017

Monrovia-based biopharmaceuticals developer Xencor announced this morning that it has named Kevin Gorman, ph.D., Gorman is the CEO of Neurocrine Biosciences, where he has been since 1993; he previously was an investor at Avalon Medical Partners, L.P. to its board of directors. Gorman replaces director Robert Baltera, Jr.,

Avalon 113

Avalon Monrovia Develop Development 113

socalTECH

MARCH 21, 2014

San Diego-based Otonomy , a biopharmaceuticals company developing treatments for disorders of the inner and middle ear, said Thursday that it has added Vickie Capps to its board of directors. Capps was previously EVP, CFO, and treasure for DJO Global, and also previously had served at Ernst & Young. READ MORE>>.

Avalon 138

Avalon San Diego Capital Develop 138

socalTECH

JUNE 4, 2012

San Diego-based Awarepoint , which develops real-time, location systems used for tracking patents and assets in a healthcare environment, said today that it has raised $14M in an additional financing round. HHIF contributed $7.5M

Avalon 140

Avalon San Diego Patents Invest 140

socalTECH

SEPTEMBER 4, 2013

According to the company, the funding was led by OrbiMed Advisors, and also included Aperture Venture Partners, Osage University Partners, as well as Avalon Ventures, Domain Associates, Novo Ventures, RiverVest Venture Partners and TPG Biotech.

Avalon 138

Avalon San Diego Equity Funding 138

socalTECH

JUNE 3, 2011

San Diego-based Otonomy , a firm developing products to treat disorders of the inner and middle ear, looks to have pulled in $14.2M in a round led by Novo Ventures and RiverVest Venture Partners, and which also included Domain Associates, TPG Biotech, and Avalon Ventures. According to the filing, the firm has now raised $24.2M

Funding 140

Funding Avalon San Diego Product 140